Abstract
Herbal and traditional medicines (HTMs) are widely used throughout the world; however, HTM-related adverse reactions, including HTM-induced liver injury, have not been fully investigated. This chapter reviewed the current status and epidemiology of HTM-induced liver injury around the world, which revealed divergent data from different countries. Not surprisingly, the most implicated species of HTM-induced liver injury are remarkably distinct between Western countries and Eastern countries, namely China; this warrants specific considerations in pharmacovigilance for HTM-induced liver injury in different areas. The main risk factors and mechanisms for HTM-induced liver injury are also summarized and discussed using Polygonum multiflorum (heshouwu; accepted name: Reynoutria multiflora (Thunb.) Moldenke) as an example.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
World Health Organization (2002) WHO Traditional medicine strategy 2002–2005. https://apps.who.int/iris/bitstream/handle/10665/67163/WHO_EDM_TRM_2002.1.pdf;jsessionid=2E85DFAFA0599960A11316226A83EE6D?sequence=1. Accessed 12 Apr 2021
Regional Committee for Africa (2000) Promoting the role of traditional medicine in health systems: a strategy for the African Region. World Health Organization. https://apps.who.int/iris/handle/10665/95467. Accessed 12 Apr 2021
World Health Organization Regional Office for the Western Pacific (1999) Traditional and modern medicine: harmonizing the two approaches: a report of the consultation meeting on traditional and modern medicine: harmonizing the two approaches, 22–26 November 1999, Beijing, China. https://apps.who.int/iris/handle/10665/207162. Accessed 12 Apr 2021
Moschik EC, Mercado C, Yoshino T, Matsuura K, Watanabe K (2012) Usage and attitudes of physicians in Japan concerning traditional Japanese medicine (Kampo medicine): A descriptive evaluation of a representative questionnaire-based survey. Evid Based Complement Alternat Med 2012:139818. https://doi.org/10.1155/2012/139818
Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD (2012) Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 12(1):45–56
Cyranoski D (2018) Why Chinese medicine is heading for clinics around the world. Nature 561(7724):448–450. https://doi.org/10.1038/d41586-018-06782-7
Wang JB, Zhu Y, Bai ZF, Wang FS, Li XH, Xiao XH (2018) Guidelines for the diagnosis and management of herb-induced liver injury. Chin J Integr Med 24(9):696–706. https://doi.org/10.1007/s11655-018-3000-8
Xiao XH, Tang J, Mao Y et al (2019) Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injury issued by China Food and Drug Administration. Acta Pharm Sin B 9(3):648–658. https://doi.org/10.1016/j.apsb.2018.12.003
Council for International Organizations of Medical Sciences (2020) Drug-induced liver injury (DILI): current status and future directions for drug development and the post-market setting. https://cioms.ch/wp-content/uploads/2020/06/CIOMS_DILI_Web_16Jun2020.pdf. Accessed 12 Apr 2021
Larrey D (2002) Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 22(2):145–155. https://doi.org/10.1055/s-2002-30105
Bjornsson ES (2014) Epidemiology and risk factors for idiosyncratic drug-induced liver injury. Semin Liver Dis 34(2):115–122. https://doi.org/10.1055/s-0034-1375953
Shen T, Liu YX, Shang J et al (2019) Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology 156(8):2230–2241.e11. https://doi.org/10.1053/j.gastro.2019.02.002
Zhu Y, Niu M, Chen J et al (2016) Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 31(8):1476–1482. https://doi.org/10.1111/jgh.13323
Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH (2017) Liver injury from herbal and dietary supplements. Hepatology 65(1):363–373. https://doi.org/10.1002/hep.28813
Cho JH, Oh DS, Hong SH et al (2017) A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol 91(12):4009–4015. https://doi.org/10.1007/s00204-017-2007-9
Xu JM (2007) A multicenter survey on hospital inpatients with drug-induced acute liver injury in China. Chin J Digestion 27(7):439–442
López-Gil S, Nuño-Lámbarri N, Chávez-Tapia N, Uribe M, Barbero-Becerra VJ (2017) Liver toxicity mechanisms of herbs commonly used in Latin America. Drug Metab Rev 49(3):338–356. https://doi.org/10.1080/03602532.2017.1335750
Valdivia-Correa B, Gómez-Gutiérrez C, Uribe M, Méndez-Sánchez N (2016) Herbal medicine in Mexico: a cause of hepatotoxicity. A critical review. Int J Mol Sci 17(2):235. https://doi.org/10.3390/ijms17020235
Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A et al (2018) Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry. Clin Gastroenterol Hepatol 16(9):1495–1502. https://doi.org/10.1016/j.cgh.2017.12.051
Vega M, Verma M, Beswick D et al (2017) The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of Delaware. Drug Saf 40(9):783–787. https://doi.org/10.1007/s40264-017-0547-9
Jing J, Teschke R (2018) Traditional Chinese medicine and herb-induced liver injury: comparison with drug-induced liver injury. J Clin Transl Hepatol 6(1):57–68. https://doi.org/10.14218/JCTH.2017.00033
Chen M, Borlak J, Tong W (2014) Predicting idiosyncratic drug-induced liver injury - some recent advances. Expert Rev Gastroenterol Hepatol 8(7):721–723. https://doi.org/10.1586/17474124.2014.922871
Mantani N, Kogure T, Sakai S et al (2002) Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method. Phytomedicine 9(4):280–287. https://doi.org/10.1078/0944-7113-00141
Suk KT, Kim DJ, Kim CH et al (2012) A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 107(9):1380–1387. https://doi.org/10.1038/ajg.2012.138
Wai CT, Tan BH, Chan CL et al (2007) Drug-induced liver injury at an Asian center: a prospective study. Liver Int 27(4):465–474. https://doi.org/10.1111/j.1478-3231.2007.01461.x
Navarro VJ, Lucena MI (2014) Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis 34(2):172–193. https://doi.org/10.1055/s-0034-1375958
Xu CY, Wang FW, Sun ZG, Chen LP (2014) Meta analysis on rates of drug-induced liver injury by Chinese herbal medicines in China. J Emerg Tradit Chin Med 11(1988–1989):2043
Maddukuri VC, Bonkovsky HL (2014) Herbal and dietary supplement hepatotoxicity. Clin Liver Dis 4(1):1–3. https://doi.org/10.1002/cld.364
Valdivia-Correa B, Gómez-Gutiérrez C, Uribe M, Méndez-Sánchez N (2016) Herbal medicine in Mexico: a cause of hepatotoxicity. a critical review. Int J Mol Sci 17(2):235–244. https://doi.org/10.3390/ijms17020235
Gao D, Pang JY, Zhang CE et al (2016) Poria attenuates idiosyncratic liver injury induced by polygoni multiflori radix praeparata. Front Pharmacol 7:386. https://doi.org/10.3389/fphar.2016.00386
Lin G, Wang JY, Li N et al (2011) Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 54(4):666–673. https://doi.org/10.1016/j.jhep.2010.07.031
Mose KF, Bygum A (2019) Chinese herbal remedy found to contain steroids and antifungals. Lancet 393(10170):446. https://doi.org/10.1016/S0140-6736(19)30116-3
Stebbings S, Beattie E, McNamara D, Hunt S (2016) A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee. Clin Rheumatol 35(7):1829–1836. https://doi.org/10.1007/s10067-015-3110-z
Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002) St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54(4):349–356. https://doi.org/10.1046/j.1365-2125.2002.01683.x
Chalasani NP, Hayashi PH, Bonkovsky HL et al (2014) ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 109(7):950–966. https://doi.org/10.1038/ajg.2014.131
He LZ, Yin P, Meng YK et al (2017) Immunological synergistic mechanisms of trans−/cis-stilbene glycosides in Heshouwu related idiosyncratic liver injury. Sci Bull 62(11):748–751
Li CP, Rao T, Chen X et al (2019) HLA-B*35:01 Allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans. Hepatology 70(1):346–357. https://doi.org/10.1002/hep.30660
Tu C, He Q, Li CY et al (2019) Susceptibility-related factor and biomarkers of dietary supplements Polygonum multiflorum-induced liver injury in rats. Front Pharmacol 10:335. https://doi.org/10.3389/fphar.2019.00335
Li CY, Tu C, Gao D et al (2016) Metabolomic study on idiosyncratic liver injury induced by different extracts of polygonum multiflorum in rats integrated with pattern recognition and enriched pathways analysis. Front Pharmacol 7:483. https://doi.org/10.3389/fphar.2016.00483
Zhang CE, Niu M, Li Q et al (2016) Urine metabolomics study on the liver injury in rats induced by raw and processed Polygonum multiflorum integrated with pattern recognition and pathways analysis. J Ethnopharmacol 194:299–306. https://doi.org/10.1016/j.jep.2016.09.011
Zhang L, Niu M, Wei AW et al (2019) Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum. Arch Toxicol 94(1):245–256. https://doi.org/10.1007/s00204-019-02595-3
Tu C, Niu M, Wei AW et al (2021) Susceptibility-related cytokine panel for prediction of Polygonum multiflorum-induced hepatotoxicity in humans. J Inflamm Res 14:645–655. https://doi.org/10.2147/JIR.S299892
Gao Y, Wang Z, Tang J et al (2020) New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions. Front Med 14(1):68–80. https://doi.org/10.1007/s11684-019-0690-z
Tang JF, Wang XY, Wen Q et al (2017) Idiosyncratic hepatotoxicity evaluation of Zhuangguguanjie wan mediated by immune stress. Acta Pharm Sin 52(7):1033–1040
Shi W, Gao Y, Guo Y et al (2019) Idiosyncratic hepatotoxicity evaluation of Cortex Dictamni based on immune stress. Acta Pharm Sin 54(4):678–686
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wang, Jb., Gao, Y., Guo, Ym., Xiao, Xh. (2022). Pharmacovigilance for Herbal and Traditional Medicine-Induced Liver Injury. In: Barnes, J. (eds) Pharmacovigilance for Herbal and Traditional Medicines. Adis, Cham. https://doi.org/10.1007/978-3-031-07275-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-07275-8_4
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-031-07273-4
Online ISBN: 978-3-031-07275-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)